Kalaris Therapeutics, Inc. (KLRS) (CIK 0001754068) CORRESP

Kalaris Therapeutics, Inc. (KLRS) (CIK 0001754068) → SEC staff · filed 2026-04-09 · ticker KLRS · SIC 2836 · view PDF on sec.gov ↗
A CORRESP letter is the company's written reply to the SEC during a filing review. Responses include accounting position arguments, restatement assessments, and clarifying disclosures. Released to EDGAR alongside the SEC's UPLOAD letters.

Key facts

Accession number
0001193125-26-149595
Form
CORRESP
Filer
Kalaris Therapeutics, Inc. (KLRS) (CIK 0001754068)
CIK
0001754068
Ticker
KLRS
Filed
2026-04-09
SIC industry
2836
HQ
Berkeley Heights, NJ

Primary source

PDF letter: https://www.sec.gov/Archives/edgar/data/1754068/000119312526149595/filename1.htm

EDGAR review index: browse all UPLOAD/CORRESP for this filer ↗

Other comment-letter activity for this filer